The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122650342 12265034 2 F 201511 20160824 20160413 20160831 EXP US-JAZZ-2016-US-006524 JAZZ 74.57 YR F Y 0.00000 20160831 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122650342 12265034 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID Y 21196 2.25 G ORAL SOLUTION
122650342 12265034 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS Y 21196 ORAL SOLUTION
122650342 12265034 3 SS XYREM SODIUM OXYBATE 1 Oral 4.5 G, BID Y 21196 4.5 G ORAL SOLUTION
122650342 12265034 4 SS XYREM SODIUM OXYBATE 1 Oral 4.25 G, BID Y 21196 4.25 G ORAL SOLUTION
122650342 12265034 5 SS XYREM SODIUM OXYBATE 1 3 G, BID Y 21196 3 G ORAL SOLUTION
122650342 12265034 6 SS XYREM SODIUM OXYBATE 1 3.25 G, BID Y 21196 3.25 G ORAL SOLUTION
122650342 12265034 7 C ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 U 0 TABLET
122650342 12265034 8 C COENZYME Q10 UBIDECARENONE 1 U 0
122650342 12265034 9 C Fluoxetine hcl FLUOXETINE HYDROCHLORIDE 1 UNK 0 CAPSULE
122650342 12265034 10 C LOVASTATIN. LOVASTATIN 1 U 0 TABLET
122650342 12265034 11 C MODAFINIL. MODAFINIL 1 U 0 TABLET
122650342 12265034 12 C OXYBUTYNIN CHLORIDE. OXYBUTYNIN CHLORIDE 1 U 0 TABLET
122650342 12265034 13 C S-ADENOSYLMETHIONINE SULFATE P-TOLUENESULFONATE ADEMETIONINE SULFATE TOSILATE 1 U 0 TABLET
122650342 12265034 14 C VITAMIN D CHOLECALCIFEROL 1 UNK 0 CAPSULE

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122650342 12265034 1 Narcolepsy
122650342 12265034 2 Cataplexy
122650342 12265034 7 Product used for unknown indication
122650342 12265034 8 Product used for unknown indication
122650342 12265034 9 Product used for unknown indication
122650342 12265034 10 Product used for unknown indication
122650342 12265034 11 Product used for unknown indication
122650342 12265034 12 Product used for unknown indication
122650342 12265034 13 Product used for unknown indication
122650342 12265034 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
122650342 12265034 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122650342 12265034 Blood cholesterol increased
122650342 12265034 Constipation
122650342 12265034 Dehydration
122650342 12265034 Depression
122650342 12265034 Fatigue
122650342 12265034 Heart rate decreased
122650342 12265034 Hypoaesthesia
122650342 12265034 Incontinence
122650342 12265034 Osteoarthritis
122650342 12265034 Osteoporosis
122650342 12265034 Retching
122650342 12265034 Sleep apnoea syndrome
122650342 12265034 Treatment noncompliance
122650342 12265034 Vomiting
122650342 12265034 Wrong technique in product usage process

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122650342 12265034 1 200306 200312 0
122650342 12265034 2 2003 2012 0
122650342 12265034 3 201204 2015 0
122650342 12265034 4 201511 0
122650342 12265034 9 201603 0
122650342 12265034 14 201604 0